SNYRQOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Synergy CHC Corp.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$0.01+0.00 (+5.26%)
Close on Oct 19, 2026
- Market cap
- $90.43K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.6820 (−99.70%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Synergy CHC Corp. saw revenue fall 17.5% to $27.70M over the twelve months to Mar 31, 2026. Operating income fell 284.7% to -$10.97M, moving the operating margin from 17.7% to -39.6%.
Revenue
$27.70M
-17.5% vs. a year earlier
Operating income
-$10.97M
-284.7% vs. a year earlier
EPS, diluted
-$1.36
-538.7% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $90.43K
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $27.70M
- Net income
- -$15.79M
- EPS, diluted
- -$1.36
- Book value per share
- -$2.25
- Diluted shares
- 11M
Eleven years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
$27.70M-17.5% YoY
Gross profit
$18.11M-21.4% YoY
Operating income
-$10.97M-284.7% YoY
Net income
-$15.79M-752.1% YoY
EPS, diluted
-$1.36-538.7% YoY
Free cash flow
–
Reported periodTrailing twelve months